{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T05:13:41Z","timestamp":1789708421437,"version":"4.0.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","jiac-j.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jiac.2024.11.007","type":"journal-article","created":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T12:08:56Z","timestamp":1731413336000},"page":"102557","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Current management and awareness of hepatitis coinfection in HIV care: A single-center retrospective study in Japan"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1705-6487","authenticated-orcid":false,"given":"Keiji","family":"Konishi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0723-0735","authenticated-orcid":false,"given":"Hiroo","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michinori","family":"Shirano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2024.11.007_bib1","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1097\/QAD.0b013e3282f8b46f","article-title":"Care of HIV patients with chronic hepatitis B: updated recommendations from the HIV-Hepatitis B Virus International Panel","volume":"22","author":"Soriano","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.jiac.2024.11.007_bib2","doi-asserted-by":"crossref","first-page":"e2205","DOI":"10.1093\/cid\/ciaa1869","article-title":"HIV Prevention Trials Network 078: high prevalence of hepatitis C virus antibodies among urban US men who have sex with men, independent of human immunodeficiency virus status","volume":"73","author":"Irvin","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2024.11.007_bib3","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1111\/hiv.13680","article-title":"Association between markers of hepatitis B virus infection and risk of virological rebound in people with HIV receiving antiretroviral therapy","volume":"25","author":"Malagnino","year":"2024","journal-title":"HIV Med"},{"key":"10.1016\/j.jiac.2024.11.007_bib4","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/QAI.0000000000003239","article-title":"Brief report: hepatitis B infection or reactivation after switch to 2-drug antiretroviral therapy: a case series, literature review, and management discussion","volume":"94","author":"Vasishta","year":"2023","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"Suppl 2","key":"10.1016\/j.jiac.2024.11.007_bib5","first-page":"ofac492","article-title":"1583. A case series of low-level HBV viremia after switching to long-acting injectable cabotegravir\/rilpivirine in patients with HIV, hepatitis B core antibody positivity, and hepatitis B surface antigen negativity","volume":"9","author":"Welford","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jiac.2024.11.007_bib6","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1097\/QAD.0000000000002973","article-title":"Patients with HIV and cirrhosis: the risk for hepatocellular carcinoma after direct-acting antivirals for hepatitis C virus","volume":"35","author":"Guardigni","year":"2021","journal-title":"AIDS"},{"key":"10.1016\/j.jiac.2024.11.007_bib7","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1086\/512367","article-title":"Do HIV care providers appropriately manage hepatitis B in coinfected patients treated with antiretroviral therapy?","volume":"44","author":"Jain","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2024.11.007_bib8","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1093\/cid\/civ654","article-title":"Low adherence of HIV providers to practice guidelines for hepatocellular carcinoma screening in HIV\/hepatitis B coinfection","volume":"61","author":"Hearn","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2024.11.007_bib9","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jiac.2024.11.007_bib10","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S1473-3099(15)00485-5","article-title":"Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis","volume":"16","author":"Platt","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jiac.2024.11.007_bib11","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1111\/hiv.13542","article-title":"Major revision version 12.0 of the European AIDS Clinical Society guidelines 2023","volume":"24","author":"Ambrosioni","year":"2023","journal-title":"HIV Med"},{"key":"10.1016\/j.jiac.2024.11.007_bib14","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/j.jhep.2005.11.015","article-title":"Natural history of chronic hepatitis B in co-infected patients","volume":"44","author":"Puoti","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.jiac.2024.11.007_bib15","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1097\/00002030-200411190-00009","article-title":"Hepatocellular carcinoma in HIV-infected patients: epidemiological features, clinical presentation and outcome","volume":"18","author":"Puoti","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.jiac.2024.11.007_bib16","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/S0140-6736(02)11913-1","article-title":"HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS)","volume":"360","author":"Thio","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jiac.2024.11.007_bib17","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/hep.510300409","article-title":"Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients","volume":"30","author":"Benhamou","year":"1999","journal-title":"The Multivirc Group. Hepatology"},{"key":"10.1016\/j.jiac.2024.11.007_bib18","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.37512","article-title":"Trends in hepatocellular carcinoma incidence and risk among persons with HIV in the US and Canada, 1996-2015","volume":"4","author":"Sun","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jiac.2024.11.007_bib19","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jhep.2007.06.010","article-title":"Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: a U.S.-Canadian multicenter study","volume":"47","author":"Br\u00e4u","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.jiac.2024.11.007_bib20","unstructured":"The Japan Society of Hepatology. Hepatitis C Treatment Guidelines (vol. 8.third ed.). https:\/\/www.jsh.or.jp\/lib\/files\/medical\/guidelines\/jsh_guidlines\/C_v8.3_20240605.pdfMay2024 [accessed 15 October 2024]."},{"key":"10.1016\/j.jiac.2024.11.007_bib21","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/hep.30183","article-title":"Hepatitis B therapy as HIV prevention in Africa: a case series from Zambia","volume":"69","author":"Vinikoor","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jiac.2024.11.007_bib22","doi-asserted-by":"crossref","DOI":"10.7448\/IAS.20.1.22146","article-title":"Elimination of HCV as a public health concern among people who inject drugs by 2030 \u2013 what will it take to get there?","volume":"20","author":"Grebely","year":"2017","journal-title":"J Int AIDS Soc"},{"key":"10.1016\/j.jiac.2024.11.007_bib23","first-page":"Cd001096","article-title":"The effects of on-screen, point of care computer reminders on processes and outcomes of care","volume":"2009","author":"Shojania","year":"2009","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X24003040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X24003040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T11:48:17Z","timestamp":1738928897000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X24003040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S1341321X24003040"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2024.11.007","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current management and awareness of hepatitis coinfection in HIV care: A single-center retrospective study in Japan","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2024.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102557"}}